Genoil Financials
This page shows Genoil (GNOLF) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing rather than operations has kept Genoil functioning, while a liability reset left liquidity improved but still thin.
Across FY2022-FY2024, operating cash outflow of-$465K to-$646K was almost fully offset by financing inflows of$470K to$651K , so cash did not stabilize because the business generated it; it stabilized because new capital kept replacing what operations consumed. At the same time, total liabilities fell from$11.1M in FY2022 to$458K in FY2024 while shares outstanding climbed from 696.0M to 1.97B, which points to balance-sheet repair that appears to have leaned more on dilution than on taking on debt.
FY2024 still shows tight near-term liquidity: cash was only
The reported entity also has a very small asset base for the size of its accumulated deficit: FY2024 total assets were just
Financial Health Signals
Based on FY2024 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Genoil's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Genoil's current ratio of 0.40 is below the typical benchmark, resulting in a score of 2/100. This tight liquidity could limit financial flexibility if cash inflows slow.
Genoil passes 0 of 9 financial strength tests. No profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Key Financial Metrics
Earnings & Revenue
Genoil generated $0 in revenue in fiscal year 2024.
Cash & Balance Sheet
Genoil held $12K in cash against $0 in long-term debt as of fiscal year 2024.
Genoil had 1.97B shares outstanding in fiscal year 2024. This represents an increase of 2.9% from the prior year.
Margins & Returns
Capital Allocation
GNOLF Income Statement
| Metric | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A |
GNOLF Balance Sheet
| Metric | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 |
|---|---|---|---|---|---|
| Total Assets | $134K-44.5% | $241K+55.6% | $155K-7.7% | $168K-15.9% | $199K |
| Current Assets | $96K+1.3% | $95K-14.6% | $112K-10.3% | $124K-20.3% | $156K |
| Cash & Equivalents | $12K+15.0% | $10K+107.5% | $5K+41933.3% | $12-99.6% | $3K |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $458K+21.9% | $376K-96.6% | $11.1M+21.0% | $9.2M+17.6% | $7.8M |
| Current Liabilities | $244K+45.5% | $168K-98.5% | $11.1M+21.0% | $9.2M+196.4% | $3.1M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$325K-140.1% | -$135K+98.8% | -$11.0M-21.6% | -$9.0M-18.5% | -$7.6M |
| Retained Earnings | -$105.9M-2.0% | -$103.8M-4.3% | -$99.5M-3.8% | -$95.9M-2.8% | -$93.3M |
GNOLF Cash Flow Statement
| Metric | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 |
|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A |
GNOLF Financial Ratios
| Metric | Q4'24 | Q4'23 | Q4'22 | Q4'21 | Q4'20 |
|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.40-0.2 | 0.57+0.6 | 0.010.0 | 0.01-0.0 | 0.05 |
| Debt-to-Equity | -1.41+1.4 | -2.78-1.8 | -1.010.0 | -1.020.0 | -1.03 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$325K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.40), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
What is Genoil's annual revenue?
Genoil (GNOLF) reported $0 in total revenue for fiscal year 2024. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What is Genoil's operating cash flow?
Genoil (GNOLF) generated -$606K in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Genoil's total assets?
Genoil (GNOLF) had $134K in total assets as of fiscal year 2024, including both current and long-term assets.
What is Genoil's current ratio?
Genoil (GNOLF) had a current ratio of 0.40 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.
What is Genoil's debt-to-equity ratio?
Genoil (GNOLF) had a debt-to-equity ratio of -1.41 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Genoil's cash runway?
Based on fiscal year 2024 data, Genoil (GNOLF) had $12K in cash against an annual operating cash burn of $606K. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Genoil's debt-to-equity ratio negative or unusual?
Genoil (GNOLF) has negative shareholder equity of -$325K as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Genoil's Piotroski F-Score?
Genoil (GNOLF) has a Piotroski F-Score of 0 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
How financially healthy is Genoil?
Genoil (GNOLF) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.